CHOLESTEROL INTERACTION WITH RECOMBINANT HUMAN STEROL CARRIER PROTEIN-2

被引:61
|
作者
COLLES, SM
WOODFORD, JK
MONCECCHI, D
MYERSPAYNE, SC
MCLEAN, LR
BILLHEIMER, JT
SCHROEDER, F
机构
[1] TEXAS A&M UNIV,TEXAS VET MED CTR,DEPT PHYSIOL & PHARMACOL,COLLEGE STN,TX 77843
[2] UNIV CINCINNATI,MED CTR,DEPT PHARMACOL & CELL BIOPHYS,DIV PHARMACOL & MED CHEM,CINCINNATI,OH 45267
[3] MARION MERRELL DOW RES INST,DEPT ANALYT & STRUCT SCI,CINCINNATI,OH 45215
[4] DUPONT MERCK PHARMACEUT CO,DEPT CARDIOVASC,WILMINGTON,DE 19898
关键词
D O I
10.1007/BF02533954
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of human recombinant sterol carrier protein-2 (SCP-2) with sterols was examined. Two independent ligand binding methods, Lipidex 1000 binding of [H-3]cholesterol and a fluorescent dehydroergosterol binding assay, were used to determine the affinity of SCP-2 for sterols. Binding analysis indicated SCP-2 bound [H-3]cholesterol and dehydroergosterol with a K-d of 0.3 and 1.7 mu M, respectively, and suggested the presence of a single binding site. Phase fluorometry and circular dichroism were used to characterize the SCP-2 sterol binding site, Alterations in dehydroergosterol lifetime, SCP-2 tryptophan lifetime, and SCP-2 tryptophan quenching by acrylamide upon cholesterol binding demonstrated a shielding of the SCP-2 tryptophan from the aqueous solvent by bound sterol. Differential polarized phase fluorometry revealed decreased SCP-2 tryptophan rotational correlation rime upon cholesterol binding. Circular dichroism of SCP-2 indicated that cholesterol elicited a small decrease in SCP-2 alpha helical content. The data suggest that SCP-2 binds sterols with affinity consistent with a lipid trans fer protein that may act either as an aqueous carrier or at a membrane surface to enhance sterol desorption.
引用
收藏
页码:795 / 803
页数:9
相关论文
共 50 条
  • [31] Sterol carrier protein-2 modulates cellular cholesterol metabolism by enhancing cholesterol transfer to the plasma membrane.
    Baum, C
    Reschly, E
    GASTROENTEROLOGY, 1996, 110 (04) : A1148 - A1148
  • [32] Fusion and Fission, the Evolution of Sterol Carrier Protein-2
    Johan Edqvist
    Kristina Blomqvist
    Journal of Molecular Evolution, 2006, 62 : 292 - 306
  • [33] CLONING AND EXPRESSION OF A CDNA-ENCODING HUMAN STEROL CARRIER PROTEIN-2
    YAMAMOTO, R
    KALLEN, CB
    BABALOLA, GO
    RENNERT, H
    BILLHEIMER, JT
    STRAUSS, JF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) : 463 - 467
  • [34] Fusion and fission, the evolution of sterol carrier protein-2
    Edqvist, J
    Blomqvist, K
    JOURNAL OF MOLECULAR EVOLUTION, 2006, 62 (03) : 292 - 306
  • [35] Sterol carrier protein-2: structure reveals function
    N.J. Stolowich
    A.D. Petrescu
    H. Huang
    G.G. Martin
    A.I. Scott
    F. Schroeder
    Cellular and Molecular Life Sciences CMLS, 2002, 59 : 193 - 212
  • [36] Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts
    Murphy, EJ
    Schroeder, F
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1345 (03): : 283 - 292
  • [37] Disruption of the sterol carrier protein-2 gene does not prevent cholesterol gallstone formation.
    Fuchs, M
    Muench, C
    Hafner, A
    Katzberg, N
    Seedorf, U
    Scheibner, J
    Stange, EF
    HEPATOLOGY, 1999, 30 (04) : 430A - 430A
  • [38] Sterol carrier protein-2 alters high density lipoprotein-mediated cholesterol efflux
    Atshaves, BP
    Starodub, O
    McIntosh, A
    Petrescu, A
    Roths, JB
    Kier, AB
    Schroeder, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) : 36852 - 36861
  • [39] Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics
    Gallegos, AM
    Atshaves, BP
    Storey, SM
    McIntosh, AL
    Petrescu, AD
    Schroeder, F
    BIOCHEMISTRY, 2001, 40 (21) : 6493 - 6506